Thursday, Jan. 26, 2023 at 10 p.m. on KPBS 2 / Watch now with the PBS Video app
The story of a drug company that pushed opioids by bribing doctors and committing insurance fraud. With the Financial Times, FRONTLINE investigates how Insys Therapeutics profited from a fentanyl-based painkiller 50 times stronger than heroin on "Opioids, Inc."
The story of a drug company that pushed opioids by bribing doctors and committing insurance fraud. With the Financial Times, FRONTLINE investigates how Insys Therapeutics profited from a fentanyl-based painkiller 50 times stronger than heroin.
Related Articles:
Insys Executives Are Sentenced to Prison Time, Putting Opioid Makers On Notice
Opioids, Bribery And Wall Street: The Inside Story Of A Disgraced Drugmaker
Opioid maker Insys Therapeutics bribed doctors to prescribe a drug that’s stronger than heroin. It’s been linked to hundreds of deaths. Speaking publicly for the first time since the criminal trial against Insys executives began, the company’s former VP of sales explains how he ran the scheme. Sales reps with “almost no conscience.” Vulnerable doctors. Quid pro quos. In his own words, WATCH what Alec Burlakoff says about how Insys bribed doctors to prescribe the opioid painkiller Subsys — and read more about the prison sentencing of Burlakoff and other Insys executives.
Watch On Your Schedule: This episode is also on demand at pbs.org/frontline, on YouTube, or with the PBS Video App.
Join The Conversation: FRONTLINE is on Facebook + Instagram+ @frontlinepbs on Twitter. #frontlinePBS
